Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M.Y Kadro"'
Publikováno v:
European Heart Journal. 41
Background In large cardiovascular (CV) outcome trials, sodium-glucose co-transporter 2 (SGLT2) inhibitors reduced the development of heart failure (HF) in patients with type 2 diabetes (T2DM). Also it reduced CV death and worsening HF events in HFrE